WASHINGTON New findings from multiple studies demonstrate that glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of medications used to treat type 2 diabetes, play a significant role in improving cardiovascular outcomes like heart failure (HF), acute myocardial infarction (AMI), peripheral artery disease (PAD), and ST-elevation myocardial infarction (STEMI)
Sam Azoulay, MD, Chief Medical Officer
The papers authors called for clinical trials to test these medicines in people with PWS
The mechanism of action involves several physiological pathways
John Myers, this cocktail is designed to support chronic conditions such as asthma, fatigue, and migraines, while promoting overall wellness and vitality
Gastrointestinal side effectsnausea, constipation, reduced appetiteare most common in the first 2-3 weeks but typically diminish by week 4